The Study
Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice
This study looked at mice that got fat from eating junk food and found that a certain type of immune cell got super active at the same time. It’s like noticing that when your phone battery dies, your screen goes dark — they happen together, but we don’t know for sure if one causes the other, especially in people.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
When you eat too much fat, special immune cells called iNKT cells get activated and tell other immune cells to start a fire in your liver and fat tissue, making you insulin resistant and causing fatty liver.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 513 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this shows that fat alone doesn't cause metabolic disease; it's the immune response triggered by fat that does, meaning targeting these cells could help treat fatty liver and diabetes.
- 2Mice without iNKT cells didn't get insulin resistance or fatty liver even when obese; mice with extra iNKT stimulation got worse insulin resistance and more liver fat — even though they didn't gain more weight.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Proceedings of the National Academy of Sciences
Year
2012
Authors
Lan Wu, Vrajesh V. Parekh, Curtis L. Gabriel, D. Bracy, Pamela A. Marks-Shulman, Robyn A Tamboli, Sungjune Kim, Y. Méndez-Fernández, G. Besra, Jefferson P. Lomenick, Brandon Williams, D. Wasserman, L. Van Kaer
Related Content
Claims (6)
Insulin resistance and chronic inflammation interact in a cycle that increases fat buildup in the liver.
In obese mice, removing invariant natural killer T cells reduces insulin resistance and fat accumulation in the liver without affecting body weight or blood lipid levels, indicating these cells directly contribute to metabolic dysfunction apart from fat mass.
In obese mice, prolonged activation of invariant natural killer T cells using α-GalCer increases insulin resistance and liver fat accumulation without changing body weight.
In obese mice, invariant natural killer T cells become active before macrophages and CD8+ T cells enter the liver and white fat, and this sequence triggers or intensifies inflammation in these tissues.
In obese mice, the lack of invariant natural killer T cells correlates with lower levels of proinflammatory cytokines and higher levels of adiponectin in white fat tissue, resulting in a less inflammatory metabolic state.
In obese mice, excess dietary fat activates iNKT cells, leading to higher levels of TNF-α and IFN-γ cytokines in the liver and fat tissue, and this is linked to the development of insulin resistance and fatty liver.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.